Regression of choroidal neovascularization results in macular atrophy in anti-vascular endothelial growth factor-treated eyes

American Journal of Ophthalmology

Volumn 159, Issue 1, 2015, Pages 9-19.e2

  Channa, Roomasa ^a   Sophie, Raafay ^a   Bagheri, Saghar ^a   Shah, Syed M ^a   Wang, Jiangxia ^b   Adeyemo, Olukemi ^a   Sodhi, Akrit ^a   Wenick, Adam ^a   Ying, Howard S ^a   Campochiaro, Peter A ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; RANIBIZUMAB; VASCULOTROPIN ANTIBODY; ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY; VASCULOTROPIN A;

AGE RELATED MACULAR DEGENERATION; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LASER COAGULATION; MACULAR DEGENERATION; PIGMENT EPITHELIUM; PRIORITY JOURNAL; REMISSION; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA TEAR; RETROSPECTIVE STUDY; RISK FACTOR; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; TREATMENT OUTCOME; VERY ELDERLY; VISUAL ACUITY; ANTAGONISTS AND INHIBITORS; CHOROIDAL NEOVASCULARIZATION; DISEASE COURSE; MALE; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; RETINA MACULA LUTEA;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; BEVACIZUMAB; CHOROIDAL NEOVASCULARIZATION; DISEASE PROGRESSION; FEMALE; HUMANS; INCIDENCE; MACULA LUTEA; MACULAR DEGENERATION; MALE; RANIBIZUMAB; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84920735881     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2014.09.012     Document Type: Article

References (19)

1. M.L. Klein, F.L.I. Ferris, and J. Armstrong Retinal precursors and the development of geographic atrophy in age-related macular degeneration Ophthalmology 115 6 2008 1026 1031
2. N. Kwak, N. Okamoto, J.M. Wood, and P.A. Campochiaro VEGF is an important stimulator in a model of choroidal neovascularization Invest Ophthalmol Vis Sci 41 10 2000 3158 3164
3. M.G. Kryzstolik, M.A. Afshari, and A.P. Adamis Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment Arch Ophthalmol 120 3 2002 338 346
4. P.J. Rosenfeld, D.M. Brown, and J.S. Heier Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 14 2006 1419 1431
5. D.M. Brown, P.K. Kaiser, and M. Michels Ranibizumab versus verteporfin for neovascular age-related macular degeneration N Engl J Med 355 14 2006 1432 1444
6. J.S. Heier, D.M. Brown, and V. Chong Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration Ophthalmology 119 12 2012 2537 2548
7. CATT Research Group D.F. Martin, and M.G. Maguire Ranibizumab and bevacizumab for neovascular age-related macular degeneration N Engl J Med 364 20 2011 1897 1908
8. Comparison of Age-related macular Degeneration Treatments Trials (CATT) Research Group D.F. Martin, and M.G. Maguire Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results Ophthalmology 119 7 2012 1388 1398
9. J.E. Grunwald, E. Daniel, and J. Huang Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials Ophthalmology 121 1 2012 150 161
10. The AREDS Research Group Change in area of geographic atrophy in the age-related eye disease study; AREDS Report Number 26 Arch Ophthalmol 127 6 2009 1168 1174
11. Age-Related Eye Disease Study Research Group A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss Arch Ophthalmol 119 10 2001 1417 1436
12. C. Cukas, E. Agron, and M. Klein Natural history of drusenoid pigment epithelial detachment in age-related macular degeneration: age-related eye disease study report no. 28 Ophthalmology 117 3 2010 489 499
13. C.J. Blair Geographic atrophy of the retinal pigment epithelium Arch Ophthalmol 93 1 1975 19 25
14. A.G. Caswell, D. Kohen, and A.C. Bird Retinal pigment epithelial detachments in the elderly: classification and outcome Br J Ophthalmol 69 6 1985 397 403
15. A. Scupola, G. Coscas, G. Soubrane, and E. Balestrazzi Natural history of macular subretinal hemrrhage in age-related macular degeneration Opthalmologica 213 2 1999 97 102
16. J. Sarks, K. Tang, M. Killingsworth, J. Arnold, and S. Sarks Development of atrophy of the retinal pigment epithelium around disciform scars Br J Ophthalmol 90 4 2006 442 446
17. W.R. Green, and C. Enger Age-related macular degeneration histopathologic studies: the 1992 Lorenz E. Zimmerman Lecture Retina 25 5 2005 1519 1535
18. J.S. Sunness, E. Margalit, and D. Srikumaran The long-term natural history of geographic atrophy from age-related macular degeneration: enlargement of atrophy and implication for interventional clinical trials Ophthalmology 114 2 2007 271 277
19. R. Klein, S.M. Meuer, M.D. Knudtson, and B.E.K. Klein The epidemiology of progression of pure geographic atrophy: the Beaver Dam Eye Study Am J Ophthalmol 146 5 2008 692 699